Work

Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities

Year: 2024

Type: article

Abstract: Summary With the incorporation of immune checkpoint inhibitors into the neoadjuvant treatment of patients with triple-negative breast cancer, we are confronted with a new toxicity profile, while adding significant improvement in pathologic complete response rates and event-free survival.

Source: memo - Magazine of European Medical Oncology

DOI: 10.1007/s12254-024-00997-3

Author: Christoph Suppan

Institution: Medical University of Graz

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,590